Atsena Therapeutics (Series C)
Funding Details
Awarder
Inbox
Date Award
May 17, 2025
Vertical
Gene Therapy
Funding Amount
$150,000,000
Company Info
Market
Genetic Medicine for Blindness
Location
Durham, North Carolina, USA
Coinvestors
Bain Capital, Wellington Management, Lightstone Ventures, Sofinnova Investments, Abingworth, Foundation Fighting Blindness, Hatteras Venture Partners, Osage University Partners, Manning Family Foundation
Company Description

Atsena Therapeutics is a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness.

Links